Anticoagulant and thrombolytic therapies in women.
Schwartz
Janice B
JB
Long-Term Care Research Center, Goldman Institute on Aging/Jewish Home, 302 Silver Ave, San Francisco, CA 94112, USA.
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D003276:Contraceptives, Oral / Q000009:adverse effects / Q000494:pharmacology; D004347:Drug Interactions; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy; D013923:Thromboembolism / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000009:adverse effects; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use
D000925:Anticoagulants; D003276:Contraceptives, Oral; D005343:Fibrinolytic Agents; D014859:Warfarin; D006493:Heparin